Literature DB >> 1737089

Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia.

R Advani1, S Sorenson, E Shinar, W Lande, E Rachmilewitz, S L Schrier.   

Abstract

The aim of the present work was to understand the pathophysiology of the severe human thalassemias as represented by beta-thalassemia intermedia and hemoglobin (Hb) H (alpha-thalassemia) disease. We have previously shown that the material properties of the red blood cell (RBC) and its membrane differ in severe alpha- and beta-thalassemia, and we now show that this difference is probably caused by accumulation of alpha-globin chains at the cytoskeleton in beta-thalassemia, whereas beta-globin chains are associated with the cytoskeleton in alpha-thalassemia. In both alpha- and beta-thalassemia, some of these globin chains have become oxidized as evidenced by loss of the free thiols. Furthermore, there is similar evidence of oxidation of protein 4.1 in beta-thalassemia, whereas beta-spectrin appears to be subject to oxidation in alpha-thalassemia. These observations support the idea that the association of partly oxidized globin chains with the cytoskeleton results in oxidation of adjacent skeletal proteins. The abnormality of protein 4.1 in beta-thalassemia is consistent with a prior observation, and is also in accord with the known importance of protein 4.1 in maintenance of membrane stability, a property that is abnormal in beta-thalassemic membranes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737089

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Insights into hemoglobin assembly through in vivo mutagenesis of α-hemoglobin stabilizing protein.

Authors:  Eugene Khandros; Todd L Mollan; Xiang Yu; Xiaomei Wang; Yu Yao; Janine D'Souza; David A Gell; John S Olson; Mitchell J Weiss
Journal:  J Biol Chem       Date:  2012-01-27       Impact factor: 5.157

2.  Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence.

Authors:  Silvana Ficarra; Ester Tellone; Bruno Giardina; Roberto Scatena; Annamaria Russo; Francesco Misiti; M Elisabetta Clementi; Deborah Colucci; Ersilia Bellocco; Giuseppina Laganà; Davide Barreca; Antonio Galtieri
Journal:  J Membr Biol       Date:  2009-02-24       Impact factor: 1.843

3.  A study of spectrin and lipid peroxidation of red blood cell membrane in thalassaemia carrier.

Authors:  D Banerjee; G Talukdar; D K Bhattacharya
Journal:  Indian J Clin Biochem       Date:  1999-07

4.  Peroxiredoxin-2 expression is increased in beta-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress.

Authors:  Alessandro Matte; Philip S Low; Franco Turrini; Mariarita Bertoldi; Maria Estela Campanella; Daniela Spano; Antonella Pantaleo; Angela Siciliano; Lucia De Franceschi
Journal:  Free Radic Biol Med       Date:  2010-05-19       Impact factor: 7.376

5.  The structure of α-haemoglobin in complex with a haemoglobin-binding domain from Staphylococcus aureus reveals the elusive α-haemoglobin dimerization interface.

Authors:  Kaavya Krishna Kumar; David A Jacques; J Mitchell Guss; David A Gell
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-07-23       Impact factor: 1.056

6.  Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia.

Authors:  P V Browne; O Shalev; F A Kuypers; C Brugnara; A Solovey; N Mohandas; S L Schrier; R P Hebbel
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

7.  Pathophysiology of the thalassemias. The Albion Walter Hewlett Award presentation.

Authors:  S L Schrier
Journal:  West J Med       Date:  1997-08

8.  The regulation of erythropoiesis by selenium in mice.

Authors:  Naveen Kaushal; Shailaja Hegde; Jeanne Lumadue; Robert F Paulson; K Sandeep Prabhu
Journal:  Antioxid Redox Signal       Date:  2011-02-25       Impact factor: 8.401

9.  Red blood cell antibodies in thalassemia patients in northern India: risk factors and literature review.

Authors:  Priti Elhence; Archana Solanki; Anupam Verma
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-22       Impact factor: 0.900

10.  Dominant beta-thalassemia with hemoglobin Hradec Kralove: enhanced hemolysis in the spleen.

Authors:  Shouichi Ohga; Akihiko Nomura; Hidetoshi Takada; Junko Kato; Hiroshi Ideguchi; Yukio Hattori; Masahiro Suda; Sachiyo Suita; Toshiro Hara
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.